Epratuzumab Tesirine (ADCT-602) is a novel CD22-targeted antibody-drug conjugate (ADC). This compound comprises a pyrrolobenzodiazepine (PBD) dimer and the active payload SG3249.
Target:
Antibody-Drug Conjugates (ADCs)
* VAT and and shipping costs not included. Errors and price changes excepted